US Edition
Published • loading... • Updated
CCHR Warns Ongoing Psychiatric Drug Approvals Persist Despite Documented Risks
A study found all 22 psychiatric drugs approved by the FDA from 2012 to 2024 lacked meaningful clinical benefit, raising concerns over public safety and rising polypharmacy.
Summary by Daily Jefferson County Union
10 Articles
10 Articles
Oskaloosa Herald+9 Reposted by 9 other sources
CCHR Warns Ongoing Psychiatric Drug Approvals Persist Despite Documented Risks
LOS ANGELES, Calif., Feb. 18, 2026 (SEND2PRESS NEWSWIRE) — More than 30 years after early warnings about antidepressant-linked suicidality and violence were downplayed, new peer-reviewed studies are again raising concerns about psychiatric drug oversight. Research published in leading psychiatric journals…
Coverage Details
Total News Sources10
Leaning Left5Leaning Right1Center3Last UpdatedBias Distribution56% Left
Bias Distribution
- 56% of the sources lean Left
56% Left
L 56%
C 33%
11%
Factuality
To view factuality data please Upgrade to Premium
